Corient Private Wealth
KURA icon

Corient Private Wealth’s Kura Oncology KURA Stock Holding History

Corient Private Wealth’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$424K Buy
+52,321
New +$449K ﹤0.01% 2117
2025
Q3 		– Sell
-13,838
Closed -$79.8K – 2633
2025
Q2 		$79.8K Buy
13,838
+810
+6% +$4.96K ﹤0.01% 2355
2025
Q1 		$86K Buy
13,028
+538
+4% +$4.19K ﹤0.01% 2186
2024
Q4 		$109K Buy
+12,490
New +$180K ﹤0.01% 2212
2023
Q1 		– Sell
-38,500
Closed -$478K – 2037
2022
Q4 		$478K Buy
+38,500
New +$560K ﹤0.01% 1155

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's KURA Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Kura Oncology (KURA) in Q1 2026: 52,321 shares worth $424K. The stake represents ﹤0.01% of the portfolio and ranks #2117 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in KURA as recently as Q2 2025.

Corient Private Wealth first reported a position in KURA in Q4 2022 and has held it in 5 quarters since. The position peaked at $478K in Q4 2022. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Corient Private Wealth held 52,321 shares of Kura Oncology worth $424K as of Q1 2026.
  • Kura Oncology was a new Corient Private Wealth position in Q1 2026.
  • Kura Oncology made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2117 holding.
  • Corient Private Wealth first reported a position in Kura Oncology in Q4 2022 and has held it in 5 quarters since.
  • Corient Private Wealth's Kura Oncology position peaked at $478K in Q4 2022.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.